Literature DB >> 12756082

Radical prostatectomy for the patient with locally advanced prostate cancer.

John F Ward1, Horst Zincke.   

Abstract

The proper management of patients with locally advanced adenocarcinoma of the prostate has been contentious and too frequently based on antiquated misconceptions. Non-extirpative treatments, even when combined with neoadjuvant hormonal therapy, are inferior to the surgical removal of the prostate for controlling local progression and distant dissemination of the cancer. Radical prostatectomy combined with early adjunctive hormonal therapy for patients with nodal metastasis is superior to all other forms of therapy and should be considered the standard of care. This approach provides survival rates comparable with patients with clinically organ-confined prostate cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12756082     DOI: 10.1007/s11934-003-0069-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  58 in total

1.  Radical surgery for advanced prostate cancer and for radiation failures.

Authors:  W J Catalona
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

2.  Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer?

Authors:  P T Scardino
Journal:  Prog Clin Biol Res       Date:  1989

3.  Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma.

Authors:  D A Kuban; A M el-Mahdi; P F Schellhammer
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

4.  Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

Authors:  M V Pilepich; K Winter; M J John; J B Mesic; W Sause; P Rubin; C Lawton; M Machtay; D Grignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

5.  Risk of prostate carcinoma death in patients with lymph node metastasis.

Authors:  L Cheng; H Zincke; M L Blute; E J Bergstralh; B Scherer; D G Bostwick
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

6.  4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer.

Authors:  C C Schulman; F M Debruyne; G Forster; F P Selvaggi; A R Zlotta; W P Witjes
Journal:  Eur Urol       Date:  2000-12       Impact factor: 20.096

7.  Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.

Authors:  Z Petrovich; G Lieskovsky; B Langholz; S Formenti; L Baert; O Streeter; D G Skinner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

8.  Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer.

Authors:  Gilbert D A Padula; Michael J Zelefsky; Ennapadam S Venkatraman; Zvi Fuks; Henry J Lee; Linda Natale; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

9.  The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.

Authors:  S A Leibel; Z Fuks; M J Zelefsky; W F Whitmore
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-01       Impact factor: 7.038

10.  Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.

Authors:  A G Aprikian; W R Fair; V E Reuter; P Sogani; H Herr; P Russo; J Sheinfeld
Journal:  Br J Urol       Date:  1994-11
View more
  2 in total

Review 1.  Surgery for locally advanced disease.

Authors:  Philippe E Spiess; Dan Leibovici; Louis L Pisters
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 3.092

2.  Laparoscopic radical prostatectomy plus extended lymph nodes dissection for cases with non-extra node metastatic prostate cancer: 5-year experience in a single Chinese institution.

Authors:  Ming-Kun Chen; Yun Luo; Hao Zhang; Jiang-Guang Qiu; Xin-Qiao Wen; Jun Pang; Jie Si-Tu; Qi-Peng Sun; Xin Gao
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-16       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.